RETINAL VEIN OCCLUSION
Clinical trials for RETINAL VEIN OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new RETINAL VEIN OCCLUSION trials appear
Sign up with your email to follow new studies for RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug ANXV aims to save sight in diabetic and vein occlusion patients
Disease control Recruiting nowThis early study tests a new drug, ANXV, in 12 adults with diabetic retinopathy or retinal vein occlusion. The main goal is to check if ANXV is safe and if it can improve vision or reduce the need for other treatments. Participants receive ANXV as a 30-minute infusion daily for 5…
Matched conditions: RETINAL VEIN OCCLUSION
Phase: PHASE2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New eye dye could make retinal scans safer
Diagnosis Recruiting nowThis early study tests a new dye called MB-102 for eye imaging (angiography) in 10 people with or without retinal diseases like diabetic retinopathy or macular degeneration. The goal is to see if MB-102 is safe and produces clear images compared to the standard dye, fluorescein s…
Matched conditions: RETINAL VEIN OCCLUSION
Phase: EARLY_PHASE1 • Sponsor: MediBeacon • Aim: Diagnosis
Last updated May 26, 2026 05:44 UTC
-
New eye scan study aims to catch retinal disease early
Knowledge-focused Recruiting nowThis study uses a special eye scan (OCT angiography) to track changes in retinal blood vessel diseases like diabetic retinopathy and vein occlusion. Researchers will follow over 1,000 participants, including healthy volunteers, to see how imaging patterns relate to disease stage.…
Matched conditions: RETINAL VEIN OCCLUSION
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 26, 2026 06:00 UTC
-
Eye protein levels may predict retina damage
Knowledge-focused Recruiting nowThis study looks at a protein called sCD160 in the eye fluids and blood of people with diabetic retinopathy or retinal vein occlusion. Researchers want to see if higher levels of this protein are linked to more severe eye damage. The goal is to better understand these vision-thre…
Matched conditions: RETINAL VEIN OCCLUSION
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Eye disease database aims to unlock secrets of vision loss
Knowledge-focused Recruiting nowThis study collects blood, tissue, and health information from people with and without retinal diseases like age-related macular degeneration and diabetic retinopathy. The goal is to create a research database to help scientists understand why some people get eye diseases and oth…
Matched conditions: RETINAL VEIN OCCLUSION
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC